SCHEMBL12087415

SCHEMBL12087415

C=C=C(OC)N1CCC2C=CC=CC2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL199019 0.67 MAPK14 (0.32) —
SCHEMBL6451753 0.67 — —
SCHEMBL7801495 0.67 PDE4B (0.34) —
SCHEMBL14379389 0.65 ITGA4 (0.34) —
SCHEMBL8229679 0.62 ADAM10 (0.34) —
SCHEMBL10154239 0.62 MRGPRX2 (0.50) —
Succinic Acid SCHEMBL2849111 0.61 MAPK14 (0.32) —
SCHEMBL18723458 0.58 — —
SCHEMBL8549931 0.58 — —
SCHEMBL13774864 0.58 ITGA4 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2495249-A1 Tertiary amine substituted peptides useful as inhibitors of HCV replication Achillion Pharmaceuticals, Inc. (US) 2012-09-05 — — EP disclosed
Send feedback